These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

491 related items for PubMed ID: 17347966

  • 1. Management of secondary hyperparathyroidism in uremic patients: the role of the new vitamin D analogs.
    Brancaccio D, Cozzolino M, Galassi A, Chiarelli G, Butti A, Bellasi A, Rocca-Rey L, Volpi A, Anelli A, Zoni U, Fusaro M, Brambilla C, Missaglia E, Crovetto C, Russo M, Longhini C, Provenzano R, Incalcaterra F, Cerasola G, Li Vecchi M, Gallieni M.
    J Nephrol; 2007; 20(1):3-9. PubMed ID: 17347966
    [Abstract] [Full Text] [Related]

  • 2. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L.
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [Abstract] [Full Text] [Related]

  • 3. Emerging role for the vitamin D receptor activator (VDRA), paricalcitol, in the treatment of secondary hyperparathyroidism.
    Cozzolino M, Brancaccio D.
    Expert Opin Pharmacother; 2008 Apr; 9(6):947-54. PubMed ID: 18377338
    [Abstract] [Full Text] [Related]

  • 4. Role of vitamin d receptor activators in cardio-renal syndromes.
    Cozzolino M, Bruschetta E, Stucchi A, Ronco C, Cusi D.
    Semin Nephrol; 2012 Jan; 32(1):63-9. PubMed ID: 22365164
    [Abstract] [Full Text] [Related]

  • 5. Vitamin D treatment in chronic kidney disease.
    Andress DL.
    Semin Dial; 2005 Jan; 18(4):315-21. PubMed ID: 16076355
    [Abstract] [Full Text] [Related]

  • 6. Cardiovascular disease in chronic kidney failure: is there a role for vitamin D analogs?
    Wu-Wong JR, Nakane M, Traylor L, Ruan X, Kroeger PE, Tian J.
    Curr Opin Investig Drugs; 2005 Mar; 6(3):245-54. PubMed ID: 15816500
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Pathogenesis and treatment of secondary hyperparathyroidism in dialysis patients: the role of paricalcitol.
    Cozzolino M, Galassi A, Gallieni M, Brancaccio D.
    Curr Vasc Pharmacol; 2008 Apr; 6(2):148-53. PubMed ID: 18393917
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Vitamin D metabolism and current options for therapeutic activation of vitamin D receptor in patients with chronic kidney disease or renal failure].
    Dusilová Sulková S.
    Vnitr Lek; 2012 Nov; 58(11):839-49. PubMed ID: 23256830
    [Abstract] [Full Text] [Related]

  • 13. Beneficial effects of better control of secondary hyperparathyroidism with paricalcitol in chronic dialysis patients.
    Capuano A, Serio V, Pota A, Memoli B, Andreucci VE.
    J Nephrol; 2009 Nov; 22(1):59-68. PubMed ID: 19229819
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Control of secondary hyperparathyroidism by vitamin D receptor agonists in chronic kidney disease.
    Sprague SM, Coyne D.
    Clin J Am Soc Nephrol; 2010 Mar; 5(3):512-8. PubMed ID: 20133492
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [Role of paracalcitol in the management of non-dialysis CKD: state of art and... Unmet needs].
    Mascia S, Garofalo C, Donnarumma G, Di Pietro R, Liberti ME, Pacilio M, Sagliocca A, Zamboli P, Minutolo R, Conte G, De Nicola L.
    G Ital Nefrol; 2010 Mar; 27(6):616-28. PubMed ID: 21132644
    [Abstract] [Full Text] [Related]

  • 19. Differential effects of vitamin D receptor activators on aortic calcification and pulse wave velocity in uraemic rats.
    Noonan W, Koch K, Nakane M, Ma J, Dixon D, Bolin A, Reinhart G.
    Nephrol Dial Transplant; 2008 Dec; 23(12):3824-30. PubMed ID: 18644798
    [Abstract] [Full Text] [Related]

  • 20. [Paricalcitol - a selective vitamin D receptor activator for secondary hyperparathyroidism in patients with chronic kidney disease].
    Matuszkiewicz-Rowińska J, Żebrowski P.
    Wiad Lek; 2016 Dec; 69(5):756-759. PubMed ID: 28033603
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.